Researchers tout PET/CT use in lung cancer treatment

04/21/2013 | Age (Melbourne, Australia), The

Researchers at the Peter MacCallum Cancer Centre in Australia said the use of PET/CT imaging in evaluating patients with advanced lung cancer helped pave the way for significant survival gains. Data gathered from PET/CT scans allowed for tailored treatment that led to a 32% four-year survival rate, up from 10% to 20%. The finding indicates that PET/CT has potential for routine clinical use and that it could also be explored for other cancers, including head and neck cancers, melanoma and some bowel cancers, a researcher said.

View Full Article in:

Age (Melbourne, Australia), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC